2017-11-22 SGB Conference Call

From HL7Wiki
Jump to navigation Jump to search

back to Standards Governance Board main page

HL7 SGB Minutes

Location:
https://global.gotomeeting.com/join/538465637

Date: 2017-11-21
Time: 10:00 AM Eastern
Facilitator Paul/Calvin Note taker(s) Anne
Attendee Name


Calvin Beebe
Lorraine Constable
Russ Hamm
Tony Julian
Paul Knapp
Austin Kreisler
Wayne Kubick
Thom Kuhn
Ken McCaslin
Rik Smithies
Sandy Stuart
Quorum: Chair + 4

Agenda

  • Agenda review
  • Approve Minutes of 2017-11-15_SGB_Conference_Call
  • Action Items
    • Paul to ask Vocab to approve a motion that it was the WG’s intention in R3 for the Expansion profile to be balloted as STU. If PA has not documented approval, send them the same message
    • Paul to verify with Karen that the documentation on the FHIR R3 ballot STU approvals is sufficient
    • All: Further review of mixed ballot content precept on 2017-11-29 call
    • Anne to add review of edited Product Life Cycle document to TSC agenda
      • Complete; TSC ran out of time this week.
  • Discussion Topics
    • Review of definition of "Standards Under Review (SUR)" definition from the Standards Privacy Impact Assessment
    • Precept implementation strategy
    • Backwards compatibility consistency and definition across families
  • Parking Lot
    • Review GOM with respect to where SGB and precepts should be reflected
    • Review Publishing M&C updates regarding dual roles
    • How do we deal with making sure that WGs involve those whose content domain they’re touching? (CIMI and Pharmacy and Lab models)
    • Review Mission and Charter
    • Handling situations where two documents come out of one project
    • FHIR Product Director Position Description: we should 1) review further and draft feedback, then 2) map back the description to the role of FGB
    • Drafting Shared Product Management Responsibilities
    • Levels of standards
    • Separation of concerns
    • Ownership of content
    • ISM
    • Ask methodology groups to define how the definition of substantive change applies to their product family; management groups must then operationalize


Minutes

Meeting Outcomes

Actions
Next Meeting/Preliminary Agenda Items

© 2017 Health Level Seven® International. All rights reserved